HIM
ZYME icon

Hillsdale Investment Management’s Zymeworks ZYME Stock Holding History

Hillsdale Investment Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Buy
382,922
+37,300
+11% +$948K 0.23% 105
2026
Q1 		$8.65M Buy
345,622
+107,700
+45% +$2.55M 0.24% 77
2025
Q4 		$6.26M Buy
237,922
+21,500
+10% +$469K 0.17% 152
2025
Q3 		$3.7M Buy
216,422
+11,400
+6% +$163K 0.11% 249
2025
Q2 		$2.57M Sell
205,022
-31,903
-13% -$380K 0.1% 255
2025
Q1 		$2.82M Buy
236,925
+6,900
+3% +$94.1K 0.14% 187
2024
Q4 		$3.37M Buy
+230,025
New +$3.22M 0.17% 169

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Hillsdale Investment Management's ZYME Position: Q2 2026 in Review

Hillsdale Investment Management increased its Zymeworks (ZYME) stake by 11% in Q2 2026, buying an estimated $948K and bringing the position to 382,922 shares worth $10M. The position accounts for 0.23% of the portfolio, ranked #105.

Hillsdale Investment Management first reported a position in ZYME in Q4 2024 and has held it in 7 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Hillsdale Investment Management held 382,922 shares of Zymeworks worth $10M as of Q2 2026.
  • Hillsdale Investment Management bought 37,300 Zymeworks shares in Q2 2026, an estimated $948K.
  • Zymeworks made up 0.23% of Hillsdale Investment Management's portfolio in Q2 2026, its #105 holding.
  • Hillsdale Investment Management first reported a position in Zymeworks in Q4 2024 and has held it in 7 quarters since.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Hillsdale Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.